Search Results - "Makarem, Mona A. Abu El"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma by Abu El Makarem, Mona A, Abdel-Aleem, Ashraf, Ali, Ahmed, Saber, Rafet, Shatat, Mohammed, Rahem, Doaa Abdel, Sayed, Douaa

    Published in Annals of hepatology (01-07-2011)
    “…Outcome of hepatocellular carcinoma (HCC) depends mainly on its early diagnosis. The performance of traditional biomarkers is not satisfactory. Osteopontin…”
    Get full text
    Journal Article
  2. 2

    The Role of Signal Transducer and Activator of Transcription 5 and Transforming Growth Factor-β1 in Hepatic Fibrosis Induced by Chronic Hepatitis C Virus Infection in Egyptian Patients by Abu El Makarem, Mona A, El-Sagheer, Ghada M, Abu El-Ella, Moustafa A

    Published in Medical principles and practice (2018)
    “…Objective: To investigate the possible role of signal transducer and activator of transcription 5 (STAT5) in the pathogenesis of liver fibrosis in Egyptian…”
    Get full text
    Journal Article
  3. 3

    Diabetes worsening of hepatitis C cirrhosis: Are alterations in monocytic tissue factor (CD 142) is the cause? by Makarem, Mona A. Abu El, Eslam, Mohammed, Sayed, Douaa, Shawkat, Mohamed, Idriss, Naglaa K, Soliman, Elwy M, Sherif, Tahra, Abdelshaheed, Ragaa, Abdelhailm, Hesham, Sahrawi, Mohamed A, Elheney, Sahar

    Published in Annals of hepatology (2014)
    “…AbstractBackground & Aim. The mechanisms by which type 2 diabetes mellitus (T2DM) worsen liver function are not yet established. Tissue factor (TF) is a…”
    Get full text
    Journal Article
  4. 4

    The coagulation changes associated with acute variceal bleeding in patients with HCV-induced cirrhosis as assessed by rotational thromboelastometry by El-Makarem, Mona A. Abu, Mohammad, Aml A, Afifi, Ola A, Abbas, Nehal I, El-Zaher, Tarek A. Abd, Halim, Safaa M. Abdel, El-Fattah, Aliaa S. Abd

    Published in Egyptian Liver Journal (08-03-2024)
    “…Background and objectivesAlterations of hemostasis in patients with decompensated cirrhosis are complex. Accordingly, standard coagulation tests are not…”
    Get full text
    Journal Article
  5. 5

    Prevalence of Occult Hepatitis B Virus Infection in Hemodialysis Patients From Egypt With or Without Hepatitis C Virus Infection by Abu El Makarem, Mona A., Abdel Hamid, Mohammed, Abdel Aleem, Ashraf, Ali, Ahmed, Shatat, Mohammed, Sayed, Douaa, Deaf, Ali, Hamdy, Lamia, Tony, Effat A.

    Published in Hepatitis monthly (01-04-2012)
    “…BACKGROUNDWhile prevalence of Hepatitis B virus (HBV) in patients with end-stage renal failure (ESRF) who are undergoing dialysis has decreased significantly…”
    Get full text
    Journal Article
  6. 6

    Non-neoplastic Portal Vein Thrombosis in HCV Cirrhosis Patients: is it an Immuno-Inflammatory Disorder? by Abu El-Makarem, Mona A, El-Akad, Atef F, Elian, Moustafa M, Sherif, Tahra M, El-shaheed, Ragaa A, Abd EL Fatah, Aliaa S, Sayed, Douaa M, Bakry, Rania M, Mahmoud, Aisha M

    Published in Annals of hepatology (01-07-2017)
    “…AbstractBackground and aimsPortal vein thrombosis (PVT) is a critical complication in cirrhotic patients. We explored the role of the activated factor…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection by Abu El Makarem, Mona A, Abdel Hamid, Mohammed, Abdel Aleem, Ashraf, Ali, Ahmed, Shatat, Mohammed, Sayed, Douaa, Deaf, Ali, Hamdy, Lamia, Tony, Effat A

    Published in Hepatitis monthly (01-04-2012)
    “…While prevalence of Hepatitis B virus (HBV) in patients with end-stage renal failure (ESRF) who are undergoing dialysis has decreased significantly during the…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The Role of Signal Transducer and Activator of Transcription 5 and Transforming Growth Factor-β 1 in Hepatic Fibrosis Induced by Chronic Hepatitis C Virus Infection in Egyptian Patients by Mona A. Abu El Makarem, El-Sagheer, Ghada M, Abu El-Ella, Moustafa A

    Published in Medical principles and practice (01-05-2018)
    “…Objective: To investigate the possible role of signal transducer and activator of transcription 5 (STAT5) in the pathogenesis of liver fibrosis in Egyptian…”
    Get full text
    Journal Article
  12. 12

    Non-neoplastic Portal Vein Thrombosis in HCV Cirrhosis Patients: is it an Immuno-Inflammatory Disorder? by Abu El-Makarem, Mona A, El-Akad, Atef F, Elian, Moustafa M, Sherif, Tahra M, El-Shaheed, Ragaa A, Abd El Fatah, Aliaa S, Sayed, Douaa M, Bakry, Rania M, Mahmoud, Aisha M

    Published in Annals of hepatology (01-07-2017)
    “…Portal vein thrombosis (PVT) is a critical complication in cirrhotic patients. We explored the role of the activated factor VII-antithrombin (FVIIa-AT) complex…”
    Get full text
    Journal Article
  13. 13

    Hepatopulmonary syndrome: prevalence and predictors in Egyptian cirrhotic patients by El Makarem, Mona A Abu, Elakad, Atef, Ali, Ahmed, Abd-Elkader, Mohammed, Sayed, Azza Farag, Taha, Amira, Abd-Elrhman, Tarek

    Published in Tropical gastroenterology (01-01-2011)
    “…The reported prevalence of hepatopulmonary syndrome (HPS) in cirrhotic patients is heterogeneous. Although the prevalence of chronic liver diseases is high in…”
    Get more information
    Journal Article